Bradley F. Bale, MD

Bradley F. Bale, MD co-founded the BaleDoneen Method® and the Heart Attack & Stroke Prevention Center. He is a principal instructor in the BaleDoneen Method, training other medical providers across the country. He has a private clinical practice in Nashville, Tennessee. He also serves as the medical director of the Heart Health Program for Grace Clinic in Lubbock, Texas.

Adjunct Professor Texas Tech Health Sciences, School of Nursing
Clinical Associate Professor Washington State University College of Medicine
Assistant Professor University of Kentucky College of Dentistry

Dr. Bradley Bale is one of the nation’s leading specialists in preventing heart attacks, stroke and diabetes. Since 2002, he’s given more than 600 speeches and presentations to medical groups in the US and abroad, including the American Heart Association, Berkeley HeartLab and European Atherosclerosis Society. His media interviews include The Huckabee Show, Fox TV, ABC TV, The Wall Street Journal and ESPN, which recently reported on how Dr. Bale screened coaches, scouts and former players from Seattle Seahawks football team for cardiovascular disease (CVD), using a state-of-the-art ultrasound test. He has also served as a medical expert on the Larry King Cardiac Foundation’s program on sudden cardiac death, honoring the late Tim Russert.

Dr. Bale is medical director of the Heart Health Program at Grace Clinic in Lubbock, Texas and cofounder of the BaleDoneen Method international preceptorship program, an accredited continuing medical education (CME) course teaching health care providers advanced techniques to detect—and reverse—CVD before the patient suffers a heart attack or stroke. Hundreds of MDs have completed the training, some of whom subsequently opened their own prevention clinics, hailing the course “an incredible resource…the future of medicine,” “the best, by far, educational program I have ever attended,” and “the education of a lifetime…the only totally comprehensive program in the world for the prevention of this disease.”

For more than 30 years, Dr. Bale maintained one of the largest primary care practices in Spokane, Washington, where he cofounded the Heart Attack Prevention Clinic with Amy Doneen, MSN, ARNP in 2003—one of the first such facilities in the US. (It’s now called the Heart Attack & Stroke Prevention Center). Convinced that standard methods of cardiac care weren’t doing enough to identify early stages of CVD and avert recurrences in heart attack and stroke survivors, he cofounded the BaleDoneen Method of personalized risk assessment and disease management in 2001. Of the 3,500 patients he’s treated with the method—including many physicians with CVD—only one had a heart attack, from which the patient made a full recovery. None of them suffered strokes.

A sought-after speaker and educator, Dr. Bale is co-chair of Berkeley Heartlab’s national five-hour CVD prevention course, which he will present in 18 cities from coast to coast this year. He made a similar tour last year, and in 2008, he lectured in 20 cities as co-chair of a national CME program on lipids and CVD. Dr. Bale has presented study abstracts at the 2009 American Heart Association meeting, the 2009 International Atherosclerosis Society meeting, the 2007 European Atherosclerosis Society Meeting, the 2005 American Heart Association conference on Arteriosclerosis, Thrombosis and Vascular Biology, and many others.

His research on CVD prevention has been published in such respected medical journals as the American Heart Association’s Circulation, Atherosclerosis, the official journal of the European Atherosclerosis Society, Post Graduate Medicine, Journal of National Medical Association, Journal of Clinical Lipidology, Physician’s Weekly, and Journal of Clinical Lipidology, ADVANCE for Administrators of the Laboratory and ADVANCE for Healthy Aging. He has also served as a reviewer for American Journal of Cardiology, a consultant to deCODE Genetics and Cleveland HeartLab, and is on the speakers’ bureaus for Takeda, diaDexus and Berkeley HeartLab.

Dr. Bale is a clinical assistant professor, School of Medicine, Texas Tech Health Sciences Center and an adjunct professor at Texas Tech’s School of Nursing. He received his Doctor of Medicine degree from University of Kentucky and his Bachelor of Arts in biochemistry from Lawrence University. He was board-certified in family medicine in 1978 and is a member of American Heart Association, American Stroke Association, American Diabetes Association, American Lipid Association, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Society of Atherosclerosis Imaging and Prevention and other medical societies. He has participated in numerous Grand Round and CME presentations and spoken at many major medical conferences.

Bradley Field Bale, M.D.
Heart Attack, Stroke and Diabetes Prevention Specialist
1002 Montrose Drive
Gallatin, TN 37066
Office: (509) 951-9348
Fax:     (615) 206-8466
Cell:    (509) 951-9346

Dr. Bradley F. Bale is a heart attack and stroke prevention specialist.  He is the co-founder of the Bale-Doneen Method for heart attack and stroke prevention. He is currently an adjunct professor the Texas Tech University Health Science Center School of Nursing.   He also is the Medical Director of Heart Health Program at Grace Clinic in Lubbock, Texas.  He was previously a professor at Texas Tech Medical School.   Dr. Bale is the co-author of numerous publications in peer reviewed medical journals and other medical publications.  He is the co-author of Beat the Heart Attack Gene (2014).  He has given CME’s throughout the United States, Canada, and Europe.  He has appeared on a number of national television programs and interviewed by hundreds of local newspapers, radio stations and television stations.  He has served as a consultant to hospitals, clinics, and medical technology companies.

B.A., 1970, Lawrence, University Appleton, WI.  Major: Bio-chemistry.
M.D., 1974, University of Kentucky, Lexington, KY
Rotating Internship, 1974-75. Sacred Heart Hospital, Spokane, WA. 

Board Certified, Family Practice, 1978
Member of American Heart and Stroke Association.
Special Purpose Exam (SPEX) – passed June, 2006.

Clinical Associate Professor WSU College of Medicine
Assistant Professor University of Kentucky College of Dentistry
Adjunct Professor Texas Tech University Health Science Center, School of Nursing
Grace Clinic, Lubbock, TX, Medical Director of Heart Health Program, 2008-present.
Co-founder of the Bale/Doneen Method international preceptorship program, a 17.5 hour CME program of CV prevention, 2010-present.
Consultant to Cleveland HeartLab, 2008 to 2017
Consultant to MyGenetx, 2015 to present
Texas Tech Medical School.  Assistant Professor of Medicine. 2007-2012
Founder of Heart Attack Prevention Clinic; Spokane, WA; 2003- 2006
Bradley F. Bale Family Practice; Spokane, WA; 1975 – 2004

American Heart Association, Member.
National Lipid Association, Member.
Society of Atherosclerosis Imaging and Prevention, Member
American Diabetic Association. Member
Healthcare in Low-resource Settings, editorial board, 2014-present
The Institute of Arteriology [] co-founder, 2014.
Reviewer for American Journal of Cardiology.
Reviewer for Preventing Chronic Disease.
Reviewer for British Journal of Medicine and Medical Research.
Diplomat of the National Board of Medical Examiners, 1975



Beat the Heart Attack Gene:  The Revolutionary Plan to Prevent Heart Disease, Stroke, and Diabetes. (Nashville, TN: John Wiley & Sons. 2014) (co-authors Amy L. Doneen and Lisa Collier).

Articles and other Publications:
“High-risk Periodontal Pathogens Contribute to the Pathogenesis of Atherosclerosis.”  Coauthored with; Doneen, A.L. and Vigerust, D.J.   Postgraduate Medicine.  2016, 93 (1098): 215-20.

“Effect of Comprehensive Cardiovascular Disease Risk Management on Longitudinal Changes in Carotid Artery Intima-media Thickness in a Community-based Prevention Clinic.” Coauthored with Cheng, H.G.; Patel, B.S.; Martin, S.S.; Blaha; M., Doneen, A. L.; Jones, S. R. Archives of Medical Science.  Aug 2016, 12, 4:728-35.  DOI: 10.5114/aoms.2016.60955

“Eight-Year Outcomes of a Program for Early Prevention of Cardiovascular Events: A Growth-Curve Analysis.”  Coauthored with Du Feng, D.; Esperat, M.C.; Doneen, A.L.; Song, H.; Green, A.E. Journal of Cardiovascular Nursing.  2015. Vol. 30, No. 4: 281-291 (2014)

“A Guarantee of Arterial Wellness: New Era of Cardiovascular Medicine.”  Coauthored with Doneen, A.L. International Journal of Clinical and Experimental Cardiology. May, 2014.  5 (3):298. doi: 10.4172/2155-9880.1000298

“Autophagy, Senescence, and Arterial Inflammation: Relationship to Arterial Health and Longevity.” Coauthored with Doneen, A.L. Alternative Therapies in Health and Medicine 2013. 19(4):8-10.

“Carotid Intima-media Thickness Testing as an Asymptomatic Cardiovascular Disease Identifier and Method for Making Therapeutic Decisions.”  Coauthored with Doneen, A.L. Postgraduate Medicine. 2013 Mar. 125(2):108-23. doi: 10.3810/pgm.2013.03.2645.

“Inculpatory Evidence: Periodontal Disease Assessment and Treatment Is an Essential Element in Cardiovascular Wellness Programs.” Coauthored with Nabors, T. and Doneen, A. L. Dental Economics 2012 September issue as CE course insert; pages 1-9.

“Clinician Perspective on the Benefits of Niacin Therapy for the Treatment of Dyslipidemia and Strategies to Improve Long-Term Adherence to Therapy:  Expert Roundtable,” Co-discussant Amy L. Doneen, moderator, Peter H. Jones.  The Medical Roundtable/Cardiovascular Edition,   Fall 2011, 2(4): 249-255.  Available online at:  • Article ID: CV9266

“Carotid Intima-Media Thickness:  Knowledge and Application to Everyday Practice.” Coauthored with Cobble, M. Postgraduate Medicine. January 2010.  122(1): 7-15.

“Optimizing Hypertension Management in Underserved Rural Populations.” Journal of National Medical Association. Jan. 2010. 102 (1): 10-17.

“The Identification of Occult Cardiovascular Disease Through the Use of a Novel Biomarker: A Case Report,” Journal of Clinical Lipidology, Oct. 2009. 3:  351–354

“Reduce Your Risk of ‘Secret’ Strokes!” Women’s World, Oct. 5, 2009, p. 15.

“Markers of Arterial Inflammation.” August 31, 2009, Physician’s Weekly, Vol. XXVI Issue No. 33.

“Arterial Inflammation Biomarkers,[Cover story], ADVANCE for Administrators of the Laboratory, July 2009.

“Aggressive Risk Factor Modification in Patients with Sub-clinical Atherosclerosis Reduces Plaque Burden and Regresses Carotid Artery Wall Thickness,” co-authored with Doneen A.L., Drueding R, and Charland S.L. Atherosclerosis 2006. 7(3): 161 [one page abstract]

“Carotid Intima-media Thickness Testing Identifies at Risk Patients Missed by Framingham 10-year Risk Scoring.” Co-authored with Doneen A.L., Charland S.L., and Smith T.F.  Atherosclerosis 2006; 7 (3):324 [one page abstract].

Presentations and Conference Abstracts:

Independent Effects of Risk Factors and Treatment on Carotid Intima-Media Thickness Progression in a Community Practice. Poster Presentation AHA Scientific Sessions, Los Angeles, November, 2012.

A1c Should Not Be Used Alone to Diagnosis Individuals at Risk of Becoming Diabetic. Accepted for Presentation – 4th International Congress on Prediabetes and Metabolic Syndrome; Madrid, Spain April 20, 2011

Insulin Resistance in Non-Diabetic Subjects Predicts Coronary Artery Disease or Coronary Artery Disease Equivalence.  Abstracts presented at the IAS meeting, Boston, June, 2009.

Patients with Atherosclerosis Missed By Framingham 10-Year Risk Scoring.  Co-authored with Amy L. Doneen.  Presented orally by Amy L. Doneen at International Atherosclerosis Society meeting, Boston, MA June 2009.

“The Prevalence of Elevated Lipoprotein Associated Phospholipase A2 Mass Among Persons at Low Risk of CHD by Traditional Framingham Risk Factors.” Presented at American Heart Association Meeting, Palm Harbor, Florida, March 2009 (subsequently published in National Lipid Association Journal).

“Effect pf Aggressive CV Risk Factor Management on Lipoproteins and Carotid Intimia-Media Thickness in Patients with Metabolic Syndrome,” European Atherosclerosis Society, Helsinki, Finland, June 2007

“Carotid Intima-media Thickness Augments Framingham Scoring in Assessing CV Risk in Metabolic Syndrome Patients,” European Atherosclerosis Society, Helsinki, Finland, June, 2007.

Effectiveness of Multiple Interventions on Carotid Artery Atherosclerosis in a Clinical Setting.  American Heart Association, 6th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology, Washington, D.C, April 28, 2005.

National Presentations:

  • Co-author of CME 5.5 hr. Cardiovascular Genetics ongoing online course May 2016.
  • Co-author and Activity Medical Director for ongoing 6.25 hr. CME and CE program: Creating Optimal Health: Integration of Medicine & Dentistry. Sponsored by U of TN Medical and Dental Schools.
  • Co-author ongoing live national program: Bale/Doneen Method Ethics Course.
  • Co-author of ongoing live national 5 hour CME program: Bale/Doneen Method Highlighting Inflammatory Testing for the Reduction of Cardiovascular Events.
  • Co-author of ongoing live national 17 hour CME program: The Bale/Doneen Method: Paradigm Shift in CVD Prevention.
  • CME lecture to Illinois State Medical Society House of Delegates Springfield, Ill 4/16/2016
  • Speaker at Ohio Seattle Study Club Cincinnati, Ohio 3/18/2016
  • National Webinar for Institute of Arteriology 11/20/2015
  • Key Note speaker LANAP Millennium Dental meeting 11/14/2015
  • Didactic Lecture U. of KY College of Medicine 10/30/2015
  • Guest speaker AAOSH meeting. Dallas, TX 9/20/2015
  • Key note speaker International Clinical and Experimental Cardiology Conference. San Antonio, TX 04/14/2014.
  • Key note speaker International Academy of Biological Dentistry and Medicine. Houston, TX 10/12/2013
  • Guest speaker 2013 AOA Public Health Seminar. Las Vegas, NV 9/30/2013.
  • Guest speaker AAOSH meeting. Las Vegas, NV 9/21/2013.
  • Guest speaker Annual Florida Endocrine Society Meeting. Orlando, FL 8/10/2013.
  • Key note speaker Delta Dental future FOCUS seminar. Saint Louis, MO 4/24/2013.
  • Guest speaker 21st Annual World Congress on Anti-aging and Regenerative Medicine. Orlando, FL 4/13/2013.
  • Key Note speaker. American Academy of Dental Practice Administration Annual Meeting at the Cosmopolitan Hotel in Las Vegas, Nevada, March 6 – 9, 2013
  • Guest speaker North Carolina Academy of Family Physicians Asheville, NC 12/2012.
  • Guest speaker at University of Nevada School of Medicine Annual Diabetes Conference, Reno, NV, September 7, 2012.
  • Key note speaker at 1st Annual American Academy of Oral Systemic Health, Chicago, Ill. 6/2011
  • Guest speaker at National FPDO Society meeting in San Antonio, TX 2/2011
  • Guest speaker at University of Nevada School of Medicine Annual Diabetes Conference, Reno, NV, September 17, 2010.
  • Guest speaker at Cleveland Heart Lab’s Annual Symposium:
    Where Inflammation Meets Lipids, Cleveland, Ohio, August 15, 2010
  • Guest on the Huckabee Show, FOX TV ‘Genetics and Medicine’, NY,NY August 2010
  • Guest speaker for two lectures –18th Annual Medical Education Conference , South Padre Island, April 1st-2nd, 2010
  • Guest speaker at TOMA – TXACOFP Annual Meeting, Fort Worth, Texas, June 17th, 2010
  • Co-chair of 5hr. Prevention Course for Berkeley Heart Lab – 18 city tour. 2/10-12/10
  • Co-chair of 5hr. Prevention Course for Berkeley Heart Lab – 18 city tour. 2/09-12/09
  • Speaker at Texas Annual DO meeting Dallas 2/09
  • Grand Rounds at Queen of the Valley Hospital,  Napa Valley, CA 12/5/2008
  • Guest speaker at the National DO Society meeting, Las Vegas, NV 10/26/2008
  • Panel member of International Roundtable regarding CIMT, Washington, DC, 9/25/2008
  • Panel member on Larry King Cardiac Foundation’s program regarding sudden cardiac death, Chicago, Ill  9/22/2008
  • Guest speaker at the AACE 2008 Post Graduate Update, Palm Beach, Florida 8/2008
  • Co-chairman of a National five hour CME program addressing the Residual Lipid Risk in CVD – 20 city tour for 2008
  • Plenary Speaker at the Texas Tech Center for CVD and Stroke Conference, August 29, 2007
  • Speaker at the Cardiology Round-up in Santa Fe, NM May, 2007
  • Speaker at National Lipid Assoc. meeting San Diego, CA 1/21/2007
  • Guest speaker at Sierra Heart Institute’s Cardiology update meeting November 2006
  • April 2005 Speaker for “Rocky Mountain Metabolic Syndrome Symposium” sponsored by the University of Colorado School of Medicine
  • Dec. 2004 Joint CME presentations with Lance Gould, M.D. titled “Preventing Heart Attacks is Better”
  • Oct. 2004 Speaker for “Traveling Faculty” meetings for Puerto Rican Society of Cardiology
  • Faculty member for national teleconference entitled, “Optimizing Care for the Patient at Risk for CHD” 2004
  • 2002 to present over six hundred national promotional presentations
  • Speaker’s bureau for: Abbott, Takeda, diaDexus, Berkeley Heart Lab

News Stories and Interviews: